Notably, tirzepatide treatment was also associated with greater improvement in insulin sensitivity per unit body weight loss than with semaglutide [19]
Eva (00:28:54): Plastic, plastic surgery and weight loss
You feel the initial effects of your first tirzepatide dose
It has benefitted from supply constraints affecting Novo Nordisk's GLP-1 agonist Ozempic (semaglutide), a key competitor, but reached the market armed with clinical data showing that it was more effective than Ozempic at controlling blood sugar levels and achieving weight loss in adults with type 2 diabetes
Ortmayr, K., Schwaiger, M., Hann, S
The pathomechanisms of obesity-associated MASLD include lipotoxicity, inflammation, fibrogenesis, and carcinogenic risk [39], suggesting that combating obesity is a major objective in treating MASLD